XML 65 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combination - Narrative (Details)
$ / shares in Units, shares in Millions, $ in Millions
1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended
Dec. 30, 2019
USD ($)
Nov. 21, 2019
USD ($)
shares
Oct. 01, 2019
USD ($)
Aug. 01, 2019
USD ($)
Oct. 01, 2018
USD ($)
Nov. 30, 2019
USD ($)
Sep. 30, 2019
$ / shares
Sep. 28, 2019
USD ($)
Mar. 28, 2020
USD ($)
Jun. 29, 2019
USD ($)
Jun. 27, 2020
USD ($)
Nov. 20, 2019
Business Acquisition [Line Items]                        
Consideration transferred   $ 69.3                    
Ownership percentage   78.00%                    
Goodwill               $ 2,563.7     $ 2,592.9  
Equity interest in acquiree, remeasurement gain   $ 3.2                    
Consideration related to equity method investment   17.9                    
Consideration related to newly acquired shares           $ 12.6            
Consideration, portion related to loan repayment   30.2                    
Business Combination, Consideration related to fair value of noncontrolling interest   8.6                    
Discount rate percentage                   0.120    
Intangible assets, net               1,459.8     $ 1,252.5  
Focal Therapeutics                        
Business Acquisition [Line Items]                        
Consideration transferred     $ 12.5   $ 120.1              
Purchase price withheld         $ 14.0         $ 1.5    
Period for payment of contingent consideration liabilities         1 year              
Goodwill         $ 31.1              
Focal Therapeutics | Developed technology                        
Business Acquisition [Line Items]                        
Identifiable intangible assets         $ 83.1              
Weighted average period         11 years              
Focal Therapeutics | In-process research and development                        
Business Acquisition [Line Items]                        
Identifiable intangible assets         $ 11.4              
Focal Therapeutics | In-process research and development | Minimum | Discount Rate                        
Business Acquisition [Line Items]                        
Intangible assets, fair value (percentage)         15.50%              
Focal Therapeutics | In-process research and development | Maximum | Discount Rate                        
Business Acquisition [Line Items]                        
Intangible assets, fair value (percentage)         16.50%              
Focal Therapeutics | Trade names                        
Business Acquisition [Line Items]                        
Identifiable intangible assets         $ 2.7              
Weighted average period         13 years              
SuperSonic Imagine                        
Business Acquisition [Line Items]                        
Consideration transferred   12.6   $ 18.2                
Equity interest in acquiree, Percentage       46.00%             81.00%  
Goodwill   22.4                    
Other assets   $ 6.5                    
Percentage of outstanding shares acquired       46.00%               50.00%
Cash tender offer price (per share) | $ / shares             $ 1.50          
Shares acquired | shares   7.6                    
Customer relationships   $ 4.0                    
Alpha Imaging [Member]                        
Business Acquisition [Line Items]                        
Consideration transferred $ 18.0                      
Holdback                   1.0    
Purchase price withheld                     $ 0.9  
Customer relationships                   $ 18.1    
Health Beacons [Member]                        
Business Acquisition [Line Items]                        
Consideration transferred                 $ 19.3      
Holdback                     2.3  
Goodwill                     5.7  
Intangible assets, net                     10.7  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities                     $ 2.9  
Other Income                        
Business Acquisition [Line Items]                        
Income (loss) from equity method investments               $ 3.3